Literature DB >> 9602348

Evolution of somatic hypermutation and gene conversion in adaptive immunity.

M Diaz1, M F Flajnik.   

Abstract

Examples of somatic hypermutation of antigen receptor genes can be seen in most lineages of vertebrates, including the cartilaginous fish. Analysis of the phylogenetic data reveals that two distinctive features of the mechanism are shared by most species studied: the mutation hot spot sequence AGY, and a preponderance of point mutations. These data suggest that some of the components of the machinery are shared between ectotherms and mammals. However, unique characters in particular species may have occurred by independent recruitment of novel factors onto the mechanism. A spotty phylogenetic distribution of gene conversion has also been revealed and can be explained if the two mechanisms share some characteristics. Both mutation and conversion require transcription-related sequences and/or factors. We theorized that targeting to V genes can be attained by a paused replication fork that has collided with a transcription complex stalled by a defective Ig transcription activator; the paused replication fork results in recruitment of an error-prone translesion synthesis DNA polymerase (somatic hypermutation) or of DNA repair mechanisms with homologous recombination (gene conversion). In addition, the pathway recruited in different species may be directed by the degree of homology among V genes.

Entities:  

Mesh:

Year:  1998        PMID: 9602348     DOI: 10.1111/j.1600-065x.1998.tb01425.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  30 in total

Review 1.  Relative roles of somatic and Darwinian evolution in shaping the antibody response.

Authors:  M Diaz; N R Klinman
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  In vivo and in vitro studies of immunoglobulin gene somatic hypermutation.

Authors:  J E Sale; M Bemark; G T Williams; C J Jolly; M R Ehrenstein; C Rada; C Milstein; M S Neuberger
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

Review 3.  Evolution and the molecular basis of somatic hypermutation of antigen receptor genes.

Authors:  M Diaz; M F Flajnik; N Klinman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

Review 4.  A new class of errant DNA polymerases provides candidates for somatic hypermutation.

Authors:  B Tippin; M F Goodman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

5.  Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ B cell line in vitro: definition of the requirements and modalities of hypermutation.

Authors:  H Zan; A Cerutti; P Dramitinos; A Schaffer; Z Li; P Casali
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

6.  The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially.

Authors:  C Rada; C Milstein
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

Review 7.  Somatic immunoglobulin hypermutation.

Authors:  Marilyn Diaz; Paolo Casali
Journal:  Curr Opin Immunol       Date:  2002-04       Impact factor: 7.486

8.  Expression of error-prone polymerases in BL2 cells activated for Ig somatic hypermutation.

Authors:  V Poltoratsky; C J Woo; B Tippin; A Martin; M F Goodman; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

9.  The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation.

Authors:  H Zan; A Komori; Z Li; A Cerutti; A Schaffer; M F Flajnik; M Diaz; P Casali
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

10.  Sequence similarities of protein kinase peptide substrates and inhibitors: comparison of their primary structures with immunoglobulin repeats.

Authors:  J Kubrycht; J Borecký; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.